Skip to main content

Government's planned increases to research and development spending examined

19 October 2021

The Science and Technology Committee holds a one-off evidence session exploring Government commitments in relation to increasing R&D investment ahead of the Autumn Budget 2022.

Witnesses

Wednesday 20 October 2021

Panel one, at 9.15am

  • Sir John Kingman, former Chair of UKRI Chair
  • Professor Dame Nancy Rothwell, President and Vice Chancellor of the University of Manchester and Chair of the Russell Group

Panel two, at 10.00am

  • Sir Paul Nurse, 2001 winner of the Nobel Prize in Physiology or Medicine, and Director of the Francis Crick Institute
  • Professor Sir Peter Ratcliffe, 2019 winner of the Nobel Prize in Physiology or Medicine and Clinical Director of the Francis Crick Institute

Panel three, at 11.00am

  • Sir Adrian Smith, President, Royal Society
  • Sir Andrew Mackenzie, Chair, UKRI
  • Lord Browne of Madingley, Co-Chair, Prime Minister’s Council for Science and Technology

The main purpose of the session is to explore the Government's planned increases to research and development spending, amid concerns about the Government reneging on its commitment to increase investment in the sector to £22 billion by 2024/25.

MPs will speak to expert witnesses to assess the spending required to fulfil plans to make the UK a 'science superpower', the support needed for the Government to deliver on its R&D roadmap, and the UK's role in international research and development collaboration.

Further information

Image: Creative Commons/CC0